Martin Doležel

559 total citations
55 papers, 423 citations indexed

About

Martin Doležel is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Martin Doležel has authored 55 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 20 papers in Radiation and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Martin Doležel's work include Advanced Radiotherapy Techniques (20 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Endometrial and Cervical Cancer Treatments (10 papers). Martin Doležel is often cited by papers focused on Advanced Radiotherapy Techniques (20 papers), Prostate Cancer Diagnosis and Treatment (13 papers) and Endometrial and Cervical Cancer Treatments (10 papers). Martin Doležel collaborates with scholars based in Czechia and United Kingdom. Martin Doležel's co-authors include Karel Odrážka, J Vaňásek, Milan Vošmik, Bohuslav Melichar, Jiřı́ Petera, Petr Paluska, Miloš Broďák, Hana Kalábová, Jan Jansa and Jiří Špaček and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, British Journal of Radiology and Clinical Chemistry and Laboratory Medicine (CCLM).

In The Last Decade

Martin Doležel

51 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Doležel Czechia 12 198 147 109 92 86 55 423
Karel Odrážka Czechia 13 244 1.2× 157 1.1× 124 1.1× 92 1.0× 107 1.2× 58 452
Tsuyoshi Takanaka Japan 14 242 1.2× 83 0.6× 221 2.0× 94 1.0× 116 1.3× 34 542
Berna Akkuş Yıldırım Türkiye 13 183 0.9× 66 0.4× 109 1.0× 177 1.9× 94 1.1× 64 484
Madoka Morota Japan 12 183 0.9× 79 0.5× 192 1.8× 104 1.1× 56 0.7× 23 429
D. Delishaj Italy 11 144 0.7× 86 0.6× 82 0.8× 130 1.4× 92 1.1× 35 447
Sara Ronchi Italy 16 314 1.6× 241 1.6× 198 1.8× 147 1.6× 189 2.2× 45 598
Haruo Inokuchi Japan 14 240 1.2× 123 0.8× 125 1.1× 149 1.6× 68 0.8× 39 483
Roman O. Kowalchuk United States 11 144 0.7× 52 0.4× 98 0.9× 84 0.9× 91 1.1× 50 367
Sei‐Chul Yoon South Korea 15 200 1.0× 109 0.7× 223 2.0× 204 2.2× 124 1.4× 25 619

Countries citing papers authored by Martin Doležel

Since Specialization
Citations

This map shows the geographic impact of Martin Doležel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Doležel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Doležel more than expected).

Fields of papers citing papers by Martin Doležel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Doležel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Doležel. The network helps show where Martin Doležel may publish in the future.

Co-authorship network of co-authors of Martin Doležel

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Doležel. A scholar is included among the top collaborators of Martin Doležel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Doležel. Martin Doležel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalita, Ondřej, Marián Hajdúch, Lumír Hrabálek, et al.. (2021). The Influence of Gene Aberrations on Survival in Resected IDH Wildtype Glioblastoma Patients: A Single-Institution Study. Current Oncology. 28(2). 1280–1293. 5 indexed citations
2.
Kalita, Ondřej, Lumír Hrabálek, Matěj Halaj, et al.. (2021). Very late complications of oncotherapy in glioblastoma patients: A case series. Biomedical Papers. 166(2). 236–241. 1 indexed citations
5.
Dušek, Ladislav, Aleš Ryška, Martin Doležel, et al.. (2020). Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer. In Vivo. 34(6). 3441–3449. 4 indexed citations
6.
Vaňásek, J, Karel Odrážka, Bohuslav Melichar, et al.. (2019). Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer. Biomedical Papers. 163(4). 285–292. 6 indexed citations
7.
Hartmann, Igor, et al.. (2016). Adrenocortical carcinoma. Urologie pro praxi. 17(5). 206–209.
8.
Melichar, Bohuslav, Pavel Veselý, Hana Kalábová, et al.. (2014). Urinary neopterin concentrations during radiotherapy for gynecological cancer. Pteridines. 25(1). 1–5. 1 indexed citations
9.
Doležel, Martin, Jakub Cvek, Ondřej Šimetka, et al.. (2014). Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: A virtual brachytherapy study. Reports of Practical Oncology & Radiotherapy. 19(6). 399–404. 14 indexed citations
10.
Hartmann, Igor, Aleš Vidlář, J. Václavík, et al.. (2014). Outcomes of adrenalectomy in patients with primary hyperaldosteronism - a single centre experience. Biomedical Papers. 158(4). 583–590. 4 indexed citations
11.
Vaňásek, J, Karel Odrážka, Martin Doležel, et al.. (2013). Statistical Analysis of Dose–Volume Profiles and its Implication for Radiation Therapy Planning in Prostate Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 86(4). 769–776. 5 indexed citations
12.
Vaňásek, J, Karel Odrážka, Ladislav Dušek, et al.. (2012). PET/CT significance for planning radiotherapy of head and neck cancer. Neoplasma. 59(5). 536–540. 5 indexed citations
14.
Odrážka, Karel, et al.. (2011). Magnetic Resonance Imaging in Postprostatectomy Radiotherapy Planning. International Journal of Radiation Oncology*Biology*Physics. 82(2). 911–918. 20 indexed citations
15.
Doležel, Martin, Karel Odrážka, J Vaňásek, et al.. (2011). MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy. British Journal of Radiology. 84(1005). 850–856. 17 indexed citations
16.
Odrážka, Karel, Martin Doležel, J Vaňásek, et al.. (2010). Chronická urinární toxicita 3D-CRT a IMRT karcinomu prostaty. 14(3). 156–163. 2 indexed citations
17.
Odrážka, Karel, Martin Doležel, J Vaňásek, et al.. (2010). Late toxicity after conformal and intensity‐modulated radiation therapy for prostate cancer: Impact of previous surgery for benign prostatic hyperplasia. International Journal of Urology. 17(9). 784–790. 20 indexed citations
18.
Broďák, Miloš, et al.. (2010). Radical Prostatectomy in High-Grade Prostate Cancer, Salvage and Adjuvant Radiotherapy. Urologia Internationalis. 86(2). 146–151. 4 indexed citations
19.
Petera, Jiřı́, et al.. (2004). High-Dose-Rate Interstitial Brachytherapy for the Treatment of Penile Carcinoma. Strahlentherapie und Onkologie. 180(2). 123–125. 8 indexed citations
20.
Dvořák, Josef, Bohuslav Melichar, Jiřı́ Petera, et al.. (2004). Liposomal Doxorubicin Combined with Regional Hyperthermia: Reducing Systemic Toxicity and Improving Locoregional Efficacy in the Treatment of Solid Tumors. Journal of Chemotherapy. 16(sup5). 34–36. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026